ELIQUIS® (apixaban) approved in Europe for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
20 November 2012 | By Bristol-Myers Squibb Company
The EC has approved ELIQUIS®...
List view / Grid view
News
Jean-Marc Pardonge appointed as new President of Aptar Pharma Prescription Division
Jean-Marc Pardonge, 52 years old, has been appointed as the new President of Aptar Pharma’s Prescription Division, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices.
Cystic Fibrosis Foundation Therapeutics announces $58 million CF drug discovery agreement with Pfizer
19 November 2012 | By Cystic Fibrosis Foundation
CFFT announced a major expansion of its research collaboration with Pfizer...
FDA approves new indication for PROMACTA® (eltrombopag)
19 November 2012 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the U.S. FDA has approved PROMACTA for the treatment of thrombocytopenia...
Pfizer reports top-line results of a Phase 3 study evaluating pregabalin controlled-release as treatment for patients with fibromyalgia
19 November 2012 | By Pfizer
Top-line results of a Phase 3 study...
Roche study showed that Avastin helped people with newly diagnosed glioblastoma live longer without their disease worsening
17 November 2012 | By Roche
Results from positive phase III AVAglio study...
A LoGiCal® solution for forensic toxicology
16 November 2012 | By kdm communications limited
LGC Standards’ LoGiCal® reference materials are proving a valuable resource for scientists at the Institute of Forensic Research...
ZALTRAP® receives CHMP positive opinion in the European Union for previously treated mCRC
16 November 2012 | By Sanofi
“We are pleased that CHMP has supported our ZALTRAP application..."
Sanofi receives positive CHMP opinion in the European Union for once-daily Lyxumia® (lixisenatide)
16 November 2012 | By Sanofi
“The CHMP positive opinion for Lyxumia marks an important milestone..."
Novartis drug Exjade® recommended by CHMP for EU approval
16 November 2012 | By Novartis
The CHMP of the EMA adopted a positive opinion for Exjade®...
GlaxoSmithKline’s Synflorix is highly effective at preventing invasive pneumococcal disease
16 November 2012 | By GlaxoSmithKline
Results from the first randomised controlled European clinical trial...
Novartis receives positive CHMP opinion for Bexsero®
16 November 2012 | By Novartis
The CHMP of the EMA has adopted a positive opinion for Bexsero for use in individuals from 2 months of age and older...
Pfizer reports top-line results of a Phase 3 study evaluating pregabalin controlled-release formulation as adjunctive treatment in adult patients with partial onset seizures
16 November 2012 | By Pfizer
Pfizer Inc., announced top-line results of a double-blind, placebo-controlled, Phase 3 study...
Roche receives positive opinion from EMA for Avastin based treatment beyond first progression in people with advanced colorectal cancer
16 November 2012 | By Roche
The continued use of Avastin based therapy beyond first progression in metastatic colorectal cancer patients leads to survival benefits...
Strathclyde awards honorary degree to world-leading cancer researcher
15 November 2012 | By University of Strathclyde
A Nobel Prize winner has been awarded an honorary degree by the University of Strathclyde...
